Merck & Co., Inc. (MRK) has released its financial results for the first quarter of 2025, showcasing a slight decrease in total sales compared to the same period […]
Roche Invests $50 Billion in U.S. Amid Tariff Concerns
To counter escalating tariffs, pharmaceutical giant Roche is investing $50 billion in the United States over the next five years. The investment will support expanding R&D facilities and […]
Eli Lilly’s Weight-Loss Pill Drives Stock Up as New Data Shows Potential
Eli Lilly has taken a major step forward in the weight-loss medication market with promising data for its new drug, indicating it could rival Ozempic from Novo Nordisk. […]
Eli Lilly’s Stock Surges as New Weight-Loss Pill Shows Promising Results
Eli Lilly’s shares surged following the announcement of this innovative pill’s efficacy, signaling a potential revolution in the weight management sector. With plans to seek regulatory approval by […]
Abbott Labs Delivers Record Q1 Earnings: Growth Fueled by Diversification
Abbott Laboratories has exceeded expectations in its first quarter of 2025, reporting robust revenue and earnings per share (EPS) growth while reaffirming its full-year outlook. The company’s diversified […]
U.S. Launches Investigations into Pharmaceutical and Chip Imports, Potential for Tariffs
The United States is actively investigating pharmaceutical and semiconductor imports, a move that signals a significant shift in its trade policy approach. These probes aim to identify potential […]
U.S. Imposes Tariffs on Imported Pharmaceuticals
President Donald Trump declared that the U.S. government has successfully addressed inflation and witnessed a rise in stock market values. This move will see the imposition of tariffs […]
Pharmaceutical Companies Face New U.S. Tariffs Impact
Major pharmaceutical companies are bracing for a wave of new tariffs set to take effect next month, potentially altering pricing strategies and supply chains. These tariffs aim to […]
Trump Imposes Major Tariffs on Pharmaceutical Imports, Aiming to Boost Domestic Manufacturing
President Trump unveiled plans for substantial tariffs on pharmaceutical imports last week, marking a strategic shift towards bolstering domestic pharmaceutical manufacturing. This move echoes his previous declaration of […]
Merk’s Stock Takes Hit Amid Rising Concerns Over Trump’s Pharmaceutical Tariffs
President Donald Trump has announced plans to impose significant tariffs on imported pharmaceuticals, potentially disrupting the long-standing practice of minimal tariffs on finished drugs. This policy shift aims […]
Trump Doubles Down on Tariffs, Threatens Pharmaceutical Import Bans
President Donald Trump escalated trade tensions during a Republican fundraising gala, announcing sweeping new tariffs and threatening further action against China. He accused other countries of ‘kissing his […]